These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37581675)

  • 1. Renin-Angiotensin System Modulation in Adults With COVID-19-Reply.
    Self WH; DeClercq J; Orr M;
    JAMA; 2023 Aug; 330(7):664-665. PubMed ID: 37581675
    [No Abstract]   [Full Text] [Related]  

  • 2. Renin-Angiotensin System Modulation in Adults With COVID-19.
    Dos Santos RAS; Taccone FS; Annoni F
    JAMA; 2023 Aug; 330(7):663-664. PubMed ID: 37581678
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs and the renin-angiotensin system in covid-19.
    Aronson JK; Ferner RE
    BMJ; 2020 Apr; 369():m1313. PubMed ID: 32241880
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19.
    Furuhashi M; Moniwa N; Takizawa H; Ura N; Shimamoto K
    Hypertens Res; 2020 Aug; 43(8):837-840. PubMed ID: 32433641
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin converting enzyme 2 at the interface between renin-angiotensin system inhibition and coronavirus disease 2019.
    Siri-Angkul N; Chattipakorn SC; Chattipakorn N
    J Physiol; 2020 Oct; 598(19):4181-4195. PubMed ID: 32710575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.
    Vaduganathan M; Vardeny O; Michel T; McMurray JJV; Pfeffer MA; Solomon SD
    N Engl J Med; 2020 Apr; 382(17):1653-1659. PubMed ID: 32227760
    [No Abstract]   [Full Text] [Related]  

  • 7. Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?
    Huang Y; Xie C; Chen X; Hong Q; Huang H
    Pharmacol Res; 2020 Sep; 159():104959. PubMed ID: 32505834
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19, hypertension, and RAAS blockers: the BRACE-CORONA trial.
    Mancia G
    Cardiovasc Res; 2020 Dec; 116(14):e198-e199. PubMed ID: 33245754
    [No Abstract]   [Full Text] [Related]  

  • 9. The renin-angiotensin-aldosterone system inhibitor dilemma in COVID-19: balancing cardiovascular benefits and viral risks.
    Okumura T; Murohara T
    Hypertens Res; 2024 Sep; 47(9):2598-2600. PubMed ID: 38951682
    [No Abstract]   [Full Text] [Related]  

  • 10. The controversy of using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 patients.
    Harky A; Chor CYT; Nixon H; Jeilani M
    J Renin Angiotensin Aldosterone Syst; 2021; 22(1):1470320320987118. PubMed ID: 33412991
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
    Shukla AK; Banerjee M
    High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 effects on the renin-angiotensin-aldosterone system, therapeutic implications.
    Ye Q; Lai EY; Luft FC; Persson PB; Mao J
    Acta Physiol (Oxf); 2021 Apr; 231(4):e13608. PubMed ID: 33350096
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiotensin Receptor Blockers Are Not Just for Hypertension Anymore.
    Saavedra JM
    Physiology (Bethesda); 2021 May; 36(3):160-173. PubMed ID: 33904788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of the Renin-Angiotensin System in Severe Acute Respiratory Syndrome-CoV-2 Infection.
    Alfano G; Guaraldi G; Fontana F; Ferrari A; Magistroni R; Mussini C; Cappelli G;
    Blood Purif; 2021; 50(2):263-267. PubMed ID: 32344395
    [No Abstract]   [Full Text] [Related]  

  • 15. Renin-Angiotensin-Aldosterone Inhibitors and COVID-19 Infection.
    Tsampasian V; Corballis N; Vassiliou VS
    Curr Hypertens Rep; 2022 Oct; 24(10):425-433. PubMed ID: 35716247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19.
    Lu L; Liu X; Jin R; Guan R; Lin R; Qu Z
    Biomed Res Int; 2020; 2020():7520746. PubMed ID: 33204713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of Antihypertensive Medications on the Outcome of Hospitalized Patients With Severe Acute Respiratory Syndrome-Coronavirus 2.
    Singh S; Offringa-Hup AK; Logtenberg SJJ; Van der Linden PD; Janssen WMT; Klein H; Waanders F; Simsek S; de Jager CPC; Smits P; van der Feltz M; Jan Beumer G; Widrich C; Nap M; Pinto-Sietsma SJ
    Hypertension; 2021 Jul; 78(1):165-173. PubMed ID: 34106731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and Liver Cirrhosis: Focus on the Nonclassical Renin-Angiotensin System and Implications for Therapy.
    Sansoè G; Aragno M; Wong F
    Hepatology; 2021 Aug; 74(2):1074-1080. PubMed ID: 33524188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme 2 as a versatile player in the management of coronavirus disease 2019.
    Amano T
    J Diabetes Investig; 2020 Sep; 11(5):1120-1122. PubMed ID: 32657484
    [No Abstract]   [Full Text] [Related]  

  • 20. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
    Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
    Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.